Adult celiac disease with thrombosis: A case series of seven patients. Role of thrombophilic factors;Maladie coeliaque de l'adulte et thromboses: à propos de sept cas. Rôle des facteurs thrombophiliques

Revue de Medecine Interne

Volumn 32, Issue 10, 2011, Pages 600-604

  Berthoux, E ^a,d   Fabien, N ^a,b,c   Chayvialle, J A ^a,d   Ninet, J ^b,d   Durieu, I ^a,b  

^a CENTRE HOSPITALIER LYON SUD   (France)

^b UNIVERSITÉ DE LYON   (France)

^c INSERM   (France)

^d EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

Antiphospholipid antibodies; Celiac disease; Hyperhomocysteinemia; Protein C deficiency; Protein S deficiency; Thrombosis

Indexed keywords

PHOSPHOLIPID ANTIBODY;

ADULT; ANTIBODY BLOOD LEVEL; ARTERY THROMBOSIS; ARTICLE; CELIAC DISEASE; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; MALE; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SPLENIC VEIN; THROMBOSIS; VEIN THROMBOSIS; VITAMIN K DEFICIENCY; BLOOD; MIDDLE AGED;

ADULT; ANTIBODIES, ANTIPHOSPHOLIPID; CELIAC DISEASE; FEMALE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; MIDDLE AGED; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; RETROSPECTIVE STUDIES; RISK FACTORS; THROMBOSIS; VITAMIN K DEFICIENCY;

EID: 80053213803     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2011.02.025     Document Type: Article

References (34)

1. Green P.H., Cellier C. Celiac disease. N Engl J Med 2007, 357:1731-1743.
2. Rousset H. Manifestations inhabituelles de la maladie cœliaque de l'adulte. Rev Med Interne 2002, 23(Suppl. 1):27s-31s.
3. Malamut G., Cellier C. Maladie cœliaque. Rev Med Interne 2010, 31:428-433.
4. Hill I.D. What are the sensitivity and specificity of serologic tests for celiac disease? Do sensitivity and specificity vary in different populations?. Gastroenterology 2005, 128:S25-S32.
5. Ben Hriz F., Habbassi H., Maamouri N., Azaiez O., Chaabouni H., Chouaib S., et al. Syndrome de Budd-Chiari associé à une maladie cœliaque. Rev Med Interne 2010, 31:160-162.
6. El Younsi S., Nassif T., Kuoch V., Boytchev I., Pelletier G., Buffet C. Association of Budd-Chiari syndrome and celiac disease. Gastroenterol Clin Biol 2003, 27:236-237.
7. Ouakaa-Kchaou A., Ennaifer R., Belhadj N., Gargouri D., Elloumi H., Romani M., et al. Maladie cœliaque associée à un syndrome de Budd-Chiari. Presse Med 2008, 37:239-241.
8. Karoui S., Sfar S., Kallel M., Boubaker J., Makni S., Filali A. Syndrome des antiphospholipides révélé par une thrombose porte au cours d'une maladie cœliaque. Rev Med Interne 2004, 25:471-473.
9. Khanna S., Chaudhary D., Kumar P., Mazumdar S. Occult celiac disease presenting as splenic vein thrombosis. Indian J Gastroenterol 2008, 27:38-39.
10. Azzam N.A., Al Ashgar H., Dababo M., Al Kahtani N., Shahid M. Mesenteric vein thrombosis as a presentation of subclinical celiac disease. Ann Saudi Med 2006, 26:471-473.
11. Lee E.S., Pulido J.S. Non ischemic central retinal vein occlusion associated with celiac disease. Mayo Clin Proc 2005, 80:157.
12. Bahloul M., Chaari A., Khlaf-Bouaziz N., Kallel H., Chaari L., Ben Hamida C., et al. Maladie cœliaque, thrombophlébite cérébrale et déficit en protéine S, une association fortuite ?. J Mal Vasc 2005, 30:228-230.
13. Durlach J. Maladie cœliaque, déficit magnésique et thrombose veineuse. Presse Med 2001, 30:904.
14. Gabrielli M., Santoliquido A., Gasbarrini G., Pola P., Gasbarrini A. Latent coeliac disease, hyperhomocysteinemia and pulmonary thromboembolism: a close link?. Thromb Haemost 2003, 89:203-204.
15. Kallel L., Matri S., Karoui S., Fekih M., Boubaker J., Filali A. Deep venous thrombosis related to protein S deficiency revealing celiac disease. Am J Gastroenterol 2009, 104:256-257.
16. Picchi A., Pasqualini P., D'Aiello I., Cortese B., Micheli A., Limbruno U. Acute ST-elevation myocardial infarction in a 15-year-old boy with celiac disease and multifactorial thrombotic risk. Thromb Haemost 2008, 99:1116-1118.
17. McNeill A., Duthie F., Galloway D.J. Small bowel infarction in a patient with coeliac disease. J Clin Pathol 2006, 59:216-218.
18. Audia S., Duchene C., Samson M., Muller G., Bielefeld P., Ricolfi F., et al. Accident vasculaire cérébral ischémique de l'adulte jeune au cours de la maladie cœliaque. À propos de deux observations. Rev Med Interne 2008, 29:228-231.
19. Saibeni S., Lecchi A., Meucci G., Cattaneo M., Tagliabue L., Rondonotti E., et al. Prevalence of hyperhomocysteinemia in adult gluten-sensitive enteropathy at diagnosis: role of B12, folate, and genetics. Clin Gastroenterol Hepatol 2005, 3:574-580.
20. NIH Consensus Development Conference on Celiac Disease. NIH Consens State Sci Statements 2004, 21:1-23. NIH.
21. Benard E., Lafuma A., Ravaud P. Epidémiologie de la maladie thromboembolique veineuse. Presse Med 2005, 34:415-419.
22. Ludvigsson J.F., Welander A., Lassila R., Ekbom A., Montgomery S.M. Risk of thromboembolism in 14,000 individuals with coeliac disease. Br J Haematol 2007, 139:121-127.
23. Guilland J.C., Favier A., Potier de Courcy G., Galan P., Hercberg S. L'homocystéine, métabolisme et implication dans le développement de diverses pathologies. Cah Nutr Dietet 2002, 37:251-259.
24. den Heijer M., Willems H.P., Blom H.J., Gerrits W.B., Cattaneo M., Eichinger S., et al. Homocysteine lowering by B vitamins and the secondary prevention of deep vein thrombosis and pulmonary embolism: a randomized, placebo-controlled, double-blind trial. Blood 2007, 109:139-144.
25. Ray J.G. Meta-analysis of hyperhomocysteinemia as a risk factor for venous thromboembolic disease. Arch Intern Med 1998, 158:2101-2106.
26. Almawi W.Y., Tamim H., Kreidy R., Timson G., Rahal E., Nabulsi M., et al. A case control study on the contribution of factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations to the genetic susceptibility of deep venous thrombosis. J Thromb Thrombolysis 2005, 19:189-196.
27. Margaglione M., D'Andrea G., d'Addedda M., Giuliani N., Cappucci G., Iannaccone L., et al. The methylenetetrahydrofolate reductase TT677 genotype is associated with venous thrombosis independently of the coexistence of the FV Leiden and the prothrombin A20210 mutation. Thromb Haemost 1998, 79:907-911.
28. Braham A., Safer L., Bdioui F., Lejmi A., Brahmi I., Ben Chabenne N., et al. Anticorps antiphospholipides en pathologie digestive. Presse Med 2001, 30:1890-1897.
29. Karoui S., Sellami M.K., Laatar A.B., Zitouni M., Matri S., Laadhar L., et al. Prevalence of anticardiolipin and anti-beta2-glycoprotein I antibodies in celiac disease. Dig Dis Sci 2007, 52:1096-1100.
30. Shamir R., Shoenfeld Y., Blank M., Eliakim R., Lahat N., Sobel E., et al. The prevalence of coeliac disease antibodies in patients with the antiphospholipid syndrome. Lupus 2003, 12:394-399.
31. Halfdanarson T.R., Litzow M.R., Murray J.A. Hematologic manifestations of celiac disease. Blood 2007, 109:412-421.
32. Schafer A.I. Thrombocytosis. N Engl J Med 2004, 350:1211-1219.
33. van Tilburg N.H., Rosendaal F.R., Bertina R.M. Thrombin activatable fibrinolysis inhibitor and the risk for deep vein thrombosis. Blood 2000, 95:2855-2859.
34. Saibeni S., Bottasso B., Spina L., Bajetta M., Danese S., Gasbarrini A., et al. Assessment of thrombin-activatable fibrinolysis inhibitor (TAFI) plasma levels in inflammatory bowel diseases. Am J Gastroenterol 2004, 99:1966-1970.